Neurologist (brain, nervous system)
8 years of experience

Accepting new patients
754 N Mt
Suite 153
Ontario, CA 91762
909-460-4155
Locations and availability (10)

Education ?

Medical School
Tehran School Of Medical Sciences (2002)
Foreign school

Awards & Distinctions ?

Associations
American Board of Psychiatry and Neurology

Affiliations ?

Dr. Jafarimojarrad is affiliated with 7 hospitals.

Hospital Affilations

Score

Rankings

  • Tri-City Regional Medical Center
    21530 Pioneer Blvd, Hawaiian Gardens, CA 90716
    • Currently 4 of 4 crosses
    Top 25%
  • Anaheim Memorial Medical Center
    1111 W La Palma Ave, Anaheim, CA 92801
    • Currently 4 of 4 crosses
    Top 25%
  • Hoag Memorial Hospital Presbyterian
    1 Hoag Dr, Newport Beach, CA 92663
    • Currently 4 of 4 crosses
    Top 25%
  • UCLA Medical Center
    10833 Le Conte Ave, Los Angeles, CA 90095
    • Currently 4 of 4 crosses
    Top 25%
  • Lakewood Regional Medical Center
    3700 South St, Lakewood, CA 90712
    • Currently 3 of 4 crosses
    Top 50%
  • Santa Monica - UCLA Medical Center
    1250 16th St, Santa Monica, CA 90404
    • Currently 3 of 4 crosses
    Top 50%
  • University of California - Ronald Reagan UCLA Medical Center
    757 Westwood Plz, Los Angeles, CA 90095
  • Publications & Research

    Dr. Jafarimojarrad has contributed to 4 publications.
    Title Diffuse Cerebral Vasoconstriction (call-fleming Syndrome) and Stroke Associated with Antidepressants.
    Date August 2006
    Journal Neurology
    Excerpt

    Call-Fleming syndrome is a reversible segmental vasoconstriction of cerebral arteries manifested by a "thunderclap" headache and focal neurologic symptoms. Although of unknown etiology, it has been reported in association with vasoactive sympathomimetic drugs. The authors report Call-Fleming syndrome in two patients with history of antidepressant use. Although the association is hypothetical, the authors suggest consideration of Call-Fleming syndrome in patients presenting with headache, focal deficits, and evidence of cerebral ischemia during antidepressant use.

    Title Lack of Association Between Early Onset of Breast Cancer and Numbers of Affected Relatives in an Iranian Population.
    Date January 2004
    Journal Familial Cancer
    Title Laddering Through Pedigrees: Family History of Malignancies in Primary Breast Cancer Patients.
    Date November 2003
    Journal Asian Pacific Journal of Cancer Prevention : Apjcp
    Excerpt

    A family history (FH) of breast cancer (BC) is a long recognized risk factor for developing the disease. Also, there have been some reports of links between an FH and some other malignancies (mostly uterus, ovary, and prostate cancers), and an increased risk of developing BC. In this paper we present descriptive report of the occurrence pattern of malignancies in families of BC afflicted patients through 4 generations. Patients included 542 Iranian primary BC cases, presenting at an outpatient clinic for treatment and follow-up. Detailed pedigrees were drawn for each patient, and data for a total of 6220 relatives were gathered. Among the probands, 29.9% and 53.9% had a positive FH of BC and other malignancies (OM) respectively. Mean number of breast cancers was nearly double in maternal-lines versus paternal-line relatives. Also, occurrence of brain, uterus, and colorectal cancers was significantly higher in maternal-line relatives, but conversely, liver cancer showed a tendency toward paternal-line relatives (1st degree relatives excluded). The highest frequency of BC involvement was noted in 2nd degree/2nd generation, and 3rd degree/3rd generation relatives. For OMs, although gastric cancer was by far the most frequent OM across pedigrees, uterus cancer, and hematopoeitic system lesions (leukemia) predominated over gastric cancer through the 3rd and 4th generations respectively. We did not find any relation between having a positive FH of BC, and developing early-onset BC. The findings discussed in this paper were partially presented at the 18th UICC International Cancer Congress, Oslo-Norway, 30 June-5 July 2002.

    Title Linking Histopathology and Family History in Breast Cancer.
    Date
    Journal Asian Pacific Journal of Cancer Prevention : Apjcp
    Excerpt

    In order to assess the prognostic value of family history (FH) of malignancies in patients afflicted with breast cancer (BC), we examined FH and histopathologic characteristics of 542 Iranian primary BC patients. Cases with distant metastasis at the time of diagnosis were excluded. Mean age of the studied population was 49 and the most common presenting stage was stage IIA followed by stage IIB. Data on a total of 6089 relatives (1st to 4th generations with the assumption of probands as the 3rd generation) were gathered. FH of BC and other malignancies (OM) was positive in 29 and 54% of cases, respectively. The most common OM's were gastric (67), lung (52) and uterus (47) cancers. We found that a FH of BC does not have any significant correlation with proven prognostic factors but a history of BC among relatives at or before the age of 36 is associated with more aggressive tumours. On the other hand, although FH of OM was associated with an older age of the probands (which is generally associated with a favourable prognosis), tumours of the cases with FH of OM had higher grades, lymphatic invasion being detected more frequently. Also we noted that the younger the age of the relatives diagnosed with cancer, the higher the stage of the probands themselves. All together our study indicates the possibility of a relation between FH of BC and OM, and histopathologic characteristics of the probands' tumours which would put forward FH as a prognostic factor rather than a simple risk factor in BC.